Abstract
Curcumin has been estimated as a potential agent for many diseases and attracted great attention owing to its various pharmacological activities, including anti-cancer, and anti-inflammatory. Now curcumin is being applied to a number of patients with breast cancer, rheumatoid arthritis, Alzheimer's disease, colorectal cancer, psoriatic, etc. Several clinical trials have stated that curcumin is safe enough and effective. The objective of this article was to summarize the clinical studies of curcumin, and give a reference for future studies.
Keywords: Curcumin, Alzheimer's disease, colorectal cancer, pancreatic cancer, breast cancer, familial adenomatous polyposis, gall-bladder contraction, tropical pancreatitis, anti-cancer, anti-inflammatory
Current Pharmaceutical Design
Title:Advances in Clinical Study of Curcumin
Volume: 19 Issue: 11
Author(s): Chunfen Yang, Xun Su, Anchang Liu, Lin Zhang, Aihua Yu, Yanwei Xi and Guangxi Zhai
Affiliation:
Keywords: Curcumin, Alzheimer's disease, colorectal cancer, pancreatic cancer, breast cancer, familial adenomatous polyposis, gall-bladder contraction, tropical pancreatitis, anti-cancer, anti-inflammatory
Abstract: Curcumin has been estimated as a potential agent for many diseases and attracted great attention owing to its various pharmacological activities, including anti-cancer, and anti-inflammatory. Now curcumin is being applied to a number of patients with breast cancer, rheumatoid arthritis, Alzheimer's disease, colorectal cancer, psoriatic, etc. Several clinical trials have stated that curcumin is safe enough and effective. The objective of this article was to summarize the clinical studies of curcumin, and give a reference for future studies.
Export Options
About this article
Cite this article as:
Yang Chunfen, Su Xun, Liu Anchang, Zhang Lin, Yu Aihua, Xi Yanwei and Zhai Guangxi, Advances in Clinical Study of Curcumin, Current Pharmaceutical Design 2013; 19 (11) . https://dx.doi.org/10.2174/1381612811319110002
DOI https://dx.doi.org/10.2174/1381612811319110002 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in the Identification of Genetic and Biochemical Components of Breast Cancer Predisposition
Current Genomics The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance
Current Medicinal Chemistry Imaging in Inflammatory Bowel Disease Mucosal Healing in Ulcerative Colitis: Relevance for Clinical Outcomes
Current Drug Targets Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets MicroRNAs in Tumorigenesis
Current Pharmaceutical Biotechnology Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology
Current Pharmaceutical Design Anti-cancer Peptides from Ras-P21 and P53 Proteins
Current Pharmaceutical Design MicroRNAs as Tools and Effectors for Patient Treatment in Gastrointestinal Carcinogenesis
Current Drug Targets Cancer Resistance to Type II Topoisomerase Inhibitors
Current Medicinal Chemistry Molecular Targeted Magnetic Resonance Imaging of Human Colorectal Carcinoma (LoVo) Cells Using Novel Superparamagnetic Iron Oxide- Loaded Nanovesicles: In Vitro and in vivo Studies
Current Cancer Drug Targets Targeted Drug Delivery Using Tuftsin-bearing Liposomes: Implications in the Treatment of Infectious Diseases and Tumors
Current Drug Targets Lipases in Medicine: An Overview
Mini-Reviews in Medicinal Chemistry Which Dose of Folic Acid Should Pregnant Diabetic Women Receive?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial: [Hot Topic: Inflammation and Cancer: New Targets and Novel Therapeutic Approach]
Current Pharmaceutical Design The Glutathione System as an Attractive Therapeutic Target
Drug Design Reviews - Online (Discontinued) New Prognostic Markers and Potential Therapeutic Targets in Human Testicular Germ Cell Tumors
Current Medicinal Chemistry Patent Selections:
Current Biomarkers (Discontinued) Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells
Current Cancer Drug Targets Silibinin – A Promising New Treatment for Cancer
Anti-Cancer Agents in Medicinal Chemistry Computational Tools in the Discovery of New G-Quadruplex Ligands with Potential Anticancer Activity
Current Topics in Medicinal Chemistry